ESMO 2023 | Challenges of delivering radiotherapy for bladder preservation in patients with bladder cancer

Robert A. Huddart, PhD, FRCR, MRCP, MBBS, The Institute of Cancer Research, London, UK, discusses the challenges of delivering radiotherapy to patients with muscle-invasive bladder cancer in the context of bladder preservation. Dr Huddart elaborates on how to ensure treatment is effective and of a high tolerability. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.